Back to Screener

Healthcare

Galenica AG(GALNF)

Live Price

Offline

$115.00

+0.00% today

1Y Change

+52.82%

Window

Jun 30, 2025 โ†’ Jun 26, 2026

Market Cap
$4.10B
Revenue Growth
+5.5%
EPS Growth
-1.1%
Dividend Yield
3.0%

Coverage: 254 bars ยท Jun 30, 2025 โ†’ Jun 26, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

Galenica AG (GALNF) is a Healthcare stock with a market cap of $4.10B and listed on OTC. The stock last traded around $115.00 and up 52.8% across the available one-year price window (Jun 30, 2025 โ†’ Jun 26, 2026). Baseline metrics include revenue growth of +5.5%, EPS growth of -1.1%, a dividend yield of 3.0%. What stands out right now is revenue +5.5%, EPS -1.1%, free cash flow +41.7% with operating margin 5.5% and ROIC 7.0%. The dividend matters to the case here, with a current yield around 3.0%. Valuation is more restrained than many high-expectation growth names at P/E 22.6 and price/sales 1.0. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines GALNF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.

Benchmark Edge

GALNF vs SPY, QQQ, and Sector ETFs

Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.

Shared 1Y chart + MAX history table

Relative Read

GALNF leads SPY

GALNF is 34.84 pts ahead over the shared 1Y window.

GALNF had 8.11 pts shallower max drawdown than SPY.

GALNF beat SPY in 1 of 2 calendar years shown and trailed in 1.

GALNF

+52.82%

Normalized return

SPY

+17.99%

S&P 500

Excess Return

+34.84 pts

Relative to SPY

GALNF Max Drawdown

-1.02%

Trailing 1Y

SPY Max Drawdown

-9.13%

Trailing 1Y

GALNFSPY

Calendar-Year Returns

Uses the longest available daily history for GALNF and SPY.

YearGALNFSPYExcessLeader
2026-1.02%+6.71%-7.73 ptsSPY
2025+54.41%+11.19%+43.21 ptsGALNF

Unable to load analyst forecasts.

Timed out loading forecasts for GALNF

Next Step

Put consensus data in context

Forecasts are most valuable when they sit beside comparisons, earnings setup, and the rest of the business story.